ReviewThe British journal of ophthalmology1998
Allergic eye disease mechanisms.
Review in The British journal of ophthalmology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- TFOS lifestyle: Impact of societal challenges on the ocular surface.The ocular surface · 2023Pooled it
- Hydrocortisone concentration influences time to clinically significant healing of acute inflammation of the ocular surface and adnexa - results from a double-blind randomized controlled trial.BMC ophthalmology · 2014Trial
- Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis.The British journal of ophthalmology · 2006Trial
- Effect of Exposure to Particulate Matter on the Ocular Surface in an Experimental Allergic Eye Disease Mouse Model.Bioengineering (Basel, Switzerland) · 2024Article
- Vernal Keratoconjunctivitis among Patients Presenting to the Outpatient Department of Ophthalmology of a Tertiary Care Centre: A Descriptive Cross-sectional Study.JNMA; journal of the Nepal Medical Association · 2023Article
- Optimization of a Plasma Rich in Growth Factors Membrane for the Treatment of Inflammatory Ocular Diseases.Bioengineering (Basel, Switzerland) · 2022Article
- Vernal keratoconjunctivitis: culmination of management using immunosuppression, surgical and prosthetic therapy over quarter century.BMJ case reports · 2016Article
- Nasal-ocular reflexes and their role in the management of allergic rhinoconjunctivitis with intranasal steroids.The World Allergy Organization journal · 2011Article
- Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.Recent patents on inflammation & allergy drug discovery · 2011Review
- Updates in the treatment of ocular allergies.Journal of asthma and allergy · 2010Article
- Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis.Molecular vision · 2010Article
- Allergic conjunctivitis and nasal allergy.Current allergy and asthma reports · 2010Article
- Human conjunctival epithelial cell responses to platelet-activating factor (PAF): signal transduction and release of proinflammatory cytokines.Molecular vision · 2009Article
- Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.MedGenMed : Medscape general medicine · 2007Review
- [Ocular allergies].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2005Review
- A review of the use of olopatadine in allergic conjunctivitis.International ophthalmology · 2004Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.